+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ovulatory Dysfunction"

Assisted Reproductive Technology Global Market Report 2024 - Product Thumbnail Image

Assisted Reproductive Technology Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
Global Female Infertility - Pipeline Insight, 2022 - Product Thumbnail Image

Global Female Infertility - Pipeline Insight, 2022

  • Drug Pipelines
  • August 2022
  • 75 Pages
  • Global
From
Female Infertility: Epidemiology Forecast to 2028 - Product Thumbnail Image

Female Infertility: Epidemiology Forecast to 2028

  • Report
  • July 2019
  • 29 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Ovulatory Dysfunction is a condition in which a woman's ovaries do not produce or release eggs regularly. It is a common cause of infertility and can be caused by a variety of factors, including hormonal imbalances, polycystic ovary syndrome, and thyroid disorders. Symptoms of ovulatory dysfunction can include irregular menstrual cycles, heavy or light bleeding, and pelvic pain. Treatment options for ovulatory dysfunction include lifestyle changes, medications, and assisted reproductive technologies. The ovulatory dysfunction market is an important part of the women's health industry. It is a growing market, with a focus on providing treatments and solutions to help women with ovulatory dysfunction conceive and have healthy pregnancies. Companies in this market are focused on developing treatments and technologies to improve fertility outcomes for women with ovulatory dysfunction. Some companies in the ovulatory dysfunction market include Ferring Pharmaceuticals, Merck, and CooperSurgical. Show Less Read more